Fab-Fc and Fab-Fab interactions of variable strength and valency contribute to the high concentration viscosity of IgG<sub>1</sub> antibodies.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41875154.
- Also identified by DOI 10.1073/pnas.2526550123 and PMC identifier 13037845.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The variable domains in Fab regions are well-established contributors to high concentration viscosity of IgG, primarily through charge and hydrophobic interactions. In contrast, the roles of the Fc and the number of self-interacting sites (valency) are less well understood. Here, we investigate the relative contributions of Fab-Fab and Fab-Fc interactions to high concentration viscosity for a diverse panel of 20 IgG<sub>1</sub> antibodies, by rheometry, coarse-grained simulations, and molecular surface property analysis. Strikingly, fragmentation of IgG<sub>1</sub> into F(ab')<sub>2</sub> plus Fc reduced viscosity (-11 to -93%) for all antibodies tested, demonstrating prevalent contributions of Fc to viscosity. Coarse-grained simulations with one site per Fab and two sites per Fc qualitatively tracked trends in experimental rheometry data for 20 parental antibodies and their fragments. In these simulations Fab-Fab and Fab-Fc interaction strengths were independently varied to capture possible interaction differences arising from parental sequences or any mutations. These coarse-grained simulations suggest that Fab-Fc attractions generate branched IgG<sub>1</sub> networks and disproportionately larger clusters relative to Fab-Fab interactions of comparable strength. This study suggests that a four-site self-interaction model, previously proposed for a single antibody (omalizumab), is broadly applicable to diverse IgG<sub>1</sub>. Beyond well-established variable domain engineering, this self-interaction model predicts that Fc engineering may reduce IgG<sub>1</sub> viscosity, a much sought after goal to enable subcutaneous delivery. Clinically validated Fc mutations are demonstrated here to substantially reduce the viscosity for multiple IgG<sub>1</sub> (-33 to -91% reduction, n = 6), supporting this emerging antibody design concept.
Medical subject headings
- Immunoglobulin Fab Fragments
- Immunoglobulin G
- Immunoglobulin Fc Fragments